Meningioma epidemiology and demographics
|
Meningioma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Meningioma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Meningioma epidemiology and demographics |
|
Risk calculators and risk factors for Meningioma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]
Overview
The incidence of meningioma is approximately 12 per 100,000 individuals in the united states.[1] The prevalence of meningioma was estimated to be 97.5 cases per 100,000 individuals in the United States.[1] Meningiomas may appear at any age, but are most commonly noticed among patients older than 50 years of age.[2] Females are more commonly affected with meningiomas than males.[1] Meningioma usually affects individuals of the african american race. Caucasian and latin american individuals are less likely to develop meningioma.[1]
Epidemiology and Demographics
Incidence
- The advent of modern sophisticated imaging studies tripled the incidence of asymptomatic meningiomas.[2]
Prevalence
- The prevalence of meningioma was estimated to be 97.5 cases per 100,000 individuals in the United States.[1]
- Meningioma is the second most common primary brain tumor worldwide.[3]
- Meningioma accounts for approximately 1 out of 3 primary brain and spinal cord tumors.[4]
- The prevalence of meningioma was estimated to be around 170,000 individuals in the United States.[1]
- Benign meningiomas account for approximately 70% of all meningioma cases.[4]
- Atypical meningiomas account for approximately 15%–25% of all meningioma cases.[4]
- Anaplastic or malignant meningiomas account for about 1%–3% of all meningioma cases.[4]
Age
- Meningiomas may appear at any age, but are most commonly noticed among patients older than 50 years of age.[2]
- Meningiomas are uncommon among patients before the age of 40 and should raise suspicion of neurofibromatosis type 2 (NF2) when found among young patients.[5]
Gender
- Females are more commonly affected with meningiomas than males.[1]
- The female to male ratio is approximately 2 to 1.[1]
- The incidence of meningioma among females is approximately 10.22 per 100,000 individuals in the united states.[6]
- The incidence of meningioma among males is approximately 4.85 per 100,000 individuals in the united states.[6]
- The female to male ratio of meningiomas may be inverted among patients who are younger than 15 years of age.[1]
Race
- Meningioma usually affects individuals of the african american race. Caucasian and latin american individuals are less likely to develop meningioma.[1]
References
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 1.9 Wiemels J, Wrensch M, Claus EB (2010). "Epidemiology and etiology of meningioma". J Neurooncol. 99 (3): 307–14. doi:10.1007/s11060-010-0386-3. PMC 2945461. PMID 20821343.
- ↑ 2.0 2.1 2.2 Meningioma. Wikipedia(2015) https://en.wikipedia.org/wiki/Meningioma#cite_note-pmid7731706-9 Accessed on September, 25th 2015
- ↑ Chamberlain MC, Barnholtz-Sloan JS (2011). "Medical treatment of recurrent meningiomas". Expert Rev Neurother. 11 (10): 1425–32. doi:10.1586/ern.11.38. PMID 21955199.
- ↑ 4.0 4.1 4.2 4.3 Meningioma. Canadian Cancer Society http://www.cancer.ca/en/cancer-information/cancer-type/brain-spinal/brain-and-spinal-tumours/meningioma/?region=mb September, 25th 2015
- ↑ Meningeoma. Radiopaedia(2015)http://radiopaedia.org/articles/meningioma Accessed on September, 25th 2015
- ↑ 6.0 6.1 Dolecek TA, Dressler EV, Thakkar JP, Liu M, Al-Qaisi A, Villano JL (2015). "Epidemiology of meningiomas post-Public Law 107-206: The Benign Brain Tumor Cancer Registries Amendment Act". Cancer. 121 (14): 2400–10. doi:10.1002/cncr.29379. PMID 25872752.